Sarah Michelle Tadijanac v. Commissioner of Social Security Administration

CourtDistrict Court, N.D. Ohio
DecidedJune 12, 2026
Docket1:25-cv-01122
StatusUnknown

This text of Sarah Michelle Tadijanac v. Commissioner of Social Security Administration (Sarah Michelle Tadijanac v. Commissioner of Social Security Administration) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sarah Michelle Tadijanac v. Commissioner of Social Security Administration, (N.D. Ohio 2026).

Opinion

IN THE UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF OHIO EASTERN DIVISION

SARAH MICHELLE TADIJANAC, CASE NO. 1:25-cv-01122

Plaintiff, JUDGE BRIDGET MEEHAN BRENNAN

vs. MAGISTRATE JUDGE AMANDA M. KNAPP

COMMISSIONER OF SOCIAL SECURITY ADMINISTRATION, REPORT AND RECOMMENDATION

Defendant.

Plaintiff Sarah Michelle Tadijanac seeks judicial review of the final decision of Defendant Commissioner of Social Security denying her applications for Child Insurance Benefits (“CIB”) and Supplemental Security Income (“SSI”). (ECF Doc. 1.) This Court has jurisdiction pursuant to 42 U.S.C. § 405(g). This matter has been referred to the undersigned Magistrate Judge for a Report and Recommendation pursuant to Local Rule 72.2. For the reasons set forth below, the undersigned recommends that the Court AFFIRM the Commissioner’s final decision. I. Procedural History Plaintiff filed her CIB and SSI applications on November 17, 2022, alleging an onset date of September 8, 2022. (Tr. 17.) She alleged disability due to ulcerative colitis, bloody stool, abdominal cramps and pain, nausea, weight loss, needing to be in close proximity to a restroom, depression, anxiety, insomnia, postural tachycardia syndrome (“POTS”), irritable bowel syndrome (“IBS”), hypokalemia, and Vitamin B12 and D deficiencies. (Tr. 117, 133, 271.) Ms. Tadijanac’s applications were denied initially and upon reconsideration (Tr. 113-22, 130-37), and she requested a hearing (Tr. 139-41). After conducting a hearing on Ms. Tadijanac’s claims (Tr. 37-65), an Administrative Law Judge (“ALJ”) issued a decision denying her applications on May 24, 2024 (Tr. 14-36). On April 4, 2025, the Appeals Council denied Ms. Tadijanac’s request to review the ALJ decision, making the May 24, 2024 decision the final decision of the

Commissioner. (Tr. 1-6.) Ms. Tadijanac filed her Complaint on May 30, 2025, challenging the Commissioner’s final decision denying her applications for disability benefits. (ECF Doc. 1.) The matter is fully briefed. (ECF Docs. 7, 9 & 10.) Ms. Tadijanac identifies two assignments of error (legal issues) in her opening brief: 1. The ALJ erred in his evaluation of Plaintiff’s mental functioning. The ALJ’s findings regarding social interaction are unsupported by substantial evidence. The ALJ failed to evaluate the prior administrative medical findings and consultative examination pursuant to the revised regulations.

2. The ALJ failed to evaluate the persuasiveness of Plaintiff’s symptoms pursuant to SSR 16-3p. The ALJ erred when failing to explain additional limitations relating to bathroom breaks should not be credited.

(ECF Doc. 7.) II. Evidence A. Personal, Educational, and Vocational Evidence Ms. Tadijanac was born in 2003 and was 19 years old on the alleged onset date, making her a younger individual, age 18-49, on the alleged disability onset date. (Tr. 30, 267.) She has a high school education. (Tr. 30, 272.) She worked part-time in the past as a cashier and store laborer. (Tr. 58-89, 272.) B. Medical Evidence 1. Relevant Treatment History In early September 2022, Ms. Tadijanac sought treatment at the emergency room multiple times for abdominal pain, constipation, vomiting, nausea, and diarrhea.1 (Tr. 352, 358,

387, 566, 572, 656.) She reported bloody stools at times. (Tr. 566.) A September 11, 2022 CT scan of the abdomen and pelvis showed: mild circumferential mucosal wall thickening of the proximal colon, nonspecific in etiology and possibly representing inflammatory or infectious process, with no signs of bowel obstruction or free air; and subcentimeter mesocolonic lymph nodes, none reaching pathological size. (Tr. 557-59, 577.) On the morning of September 11, 2022, Ms. Tadijanac rated her pain a 7 out of 10. (Tr. 566.) She was diagnosed with acute colitis, abdominal pain, and hypokalemia (Tr. 578) and prescribed antibiotics and steroids (Tr. 656). She returned to the emergency room later that same day, saying she had not made it to the pharmacy to pick up her prescriptions and was concerned she was not feeling any better. (Id.) Her pain level was a 10 out of 10. (Tr. 650.) She said she was unable to eat or drink and had

lost fifty pounds since December. (Tr. 656.) She was administered IV antibiotics and steroids and given Phenergan. (Tr. 658.) She said she would be able to pick up her prescriptions the next day and she was instructed to follow up with gastroenterology. (Id.) On September 16, 2022, Ms. Tadijanac presented to Lora Harris, APRN-CNP, at Akron Children’s Hospital for follow up after being treated in the emergency room. (Tr. 386-87.) She was given a letter excusing her from work until she could be seen and was cleared by a gastroenterologist. (Tr. 387.) Ms. Tadijanac reported there were times when she felt better when on her medication, but she said she also had “flare ups.” (Id.) She was able to keep some food

1 She presented to Avita Ontario Emergency Department on September 6 and September 9 (Tr. 352, 358) and she presented to University Hospitals on September 11 in the morning and later that same day (Tr. 566, 656.) down while on steroids. (Id.) She continued to have blood in her stools, but the frequency of her bowel movements had decreased. (Id.) She reported more anxiety and depression due to her new diagnosis of colitis and dietary changes. (Id.) On examination, her abdomen was soft, but with mild abdominal tenderness in the lower abdomen. (Tr. 388.) There was no distension,

mass, or hepatosplenomegaly. (Id.) Ms. Tadijanac was scheduled to see gastroenterologist Dale Thomae, D.O., at University Hospitals and was advised to continue with her prescribed medication. (Tr. 387.) On September 19, 2022, Ms. Tadijanac established care with Dr. Thomae. (Tr. 451-53.) She reported her diarrhea and bleeding had stopped since completing her Prednisone prescription, but she still had a lot of abdominal pain, and she felt constipated and bloated. (Tr. 451.) On examination, her abdomen was soft and non-tender. (Tr. 453.) Bowel sounds were normal. (Id.) Her bilateral lower quadrants were tender without rebound, guarding, or mass, and there was no hepatomegaly or splenomegaly. (Id.) Dr. Thomae ordered a colonoscopy and prescribed Prednisone. (Tr. 451.)

Ms. Tadijanac returned to Dr. Thomae on October 18, 2022. (Tr. 448-50.) Her mother accompanied her to the appointment. (Tr. 448.) Ms. Tadijanac reported that she lost her job due to her illness and had been unable to work consistently for the prior four months due to her bowel issues. (Id.) Ms. Tadijanac also reported concerns about starting a job because she still had to go to bathroom eight to ten times per day. (Id.) Dr. Thomae told her and her mother that “there would be no reason why she could not work and have a normal life” once her disease was under control. (Id.) The colonoscopy showed disease activity that was mild to moderate and consistent with ulcerative colitis. (Tr. 448, 458.) On examination, her abdomen was soft and non-tender. (Tr. 450.) Bowel sounds were normal and there was no hepatomegaly or splenomegaly. (Id.) Dr. Thomae prescribed dicyclomine (Bentyl) for her ulcerative colitis. (Tr. 448.) Ms. Tadijanac had previously been prescribed mesalamine but had only recently picked up the prescription. (Id.) Dr. Thomae wanted to see Ms. Tadijanac in six weeks to see how she was responding to oral mesalamine. (Id.)

On November 2, 2022, Ms. Tadijanac presented to Meredith Hale, D.O., at University Hospitals to establish care with a primary care physician. (Tr. 457-60.) Dr. Hale noted a history of ulcerative colitis, anxiety and depression, and dysmenorrhea. (Id.) Ms. Tadijanac reported that she stopped taking Prednisone due to side effects that included dizziness, lightheadedness, nausea, and suicidal ideation. (Tr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Thomas v. Arn
474 U.S. 140 (Supreme Court, 1986)
Bowen v. Yuckert
482 U.S. 137 (Supreme Court, 1987)
Ruby E. Heston v. Commissioner of Social Security
245 F.3d 528 (Sixth Circuit, 2001)
Angela M. Jones v. Commissioner of Social Security
336 F.3d 469 (Sixth Circuit, 2003)
Robert M. Wilson v. Commissioner of Social Security
378 F.3d 541 (Sixth Circuit, 2004)
David Bowen v. Commissioner of Social Security
478 F.3d 742 (Sixth Circuit, 2007)
Debra Rogers v. Commissioner of Social Security
486 F.3d 234 (Sixth Circuit, 2007)
Blakley v. Commissioner of Social Security
581 F.3d 399 (Sixth Circuit, 2009)
Fleischer v. Astrue
774 F. Supp. 2d 875 (N.D. Ohio, 2011)
Gaskin v. Commissioner of Social Security
280 F. App'x 472 (Sixth Circuit, 2008)
Doris Poe v. Commissioner of Social Security
342 F. App'x 149 (Sixth Circuit, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
Sarah Michelle Tadijanac v. Commissioner of Social Security Administration, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sarah-michelle-tadijanac-v-commissioner-of-social-security-administration-ohnd-2026.